Most people don’t realize the medical issues that could be hiding in their DNA. One company is helping bring them to light with at-home genetic testing, though it wasn’t available for New York State residents until recently.
23andme, a personal genetics company, started offering genome-testing services by sending customers an at-home saliva collection kit. The kits, which sell for $199, are mailed back to 23andme, which then tests the specimen.
According to New York State law, citizens previously could not send saliva samples out-of-state; this is because the state’s health department barred such testing without the involvement of a physician. Since 23andme is based in California, this quickly became an issue for New York State residents hoping to use the service.
However, after going through the necessary channels with the Federal Drug Administration (FDA), 23andme were able to classify their service as an “over-the-counter device.” This provides a loophole for New York residents, who can now take advantage of these services.
More than half of Americans over the age of 50 stated that a smile is the one physical cheap ativan feature that stays attractive with aging, according to a survey by the American Academy of Cosmetic Dentistry. Yet while a healthy smile makes for a great first impression, it’s not always a true indicator of overall health.
Testing of the genomes can reveal ancestry information, such as the origins of one’s original ancestors. It is also possible to determine if a person is a carrier for a genetic condition, such as cystic fibrosis, sickle cell anemia, and hereditary hearing loss.
According to the 23andme website, their mission is to help provide genetic information to the general population without having to go through a physician. However, their business has dealt with a series of setbacks in its short life.
At the beginning of its tenure, 23andme was ordered to cease and desist by the FDA after their service was deemed an “unlicensed medical device.” According to the Consumer Affairs website, this resulted in a halt in operations, yet after an investigation, the FDA lifted the ban.